Tissue-specific antibodies in myasthenia gravis.
D000109:Acetylcholine / Q000276:immunology; D000918:Antibody Specificity; D000936:Antigen-Antibody Complex; D001323:Autoantibodies / Q000276:immunology*; D001667:Binding, Competitive; D002038:Bungarotoxins / Q000494:pharmacology; D005132:Eye Manifestations; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000139:chemically induced / Q000151:congenital / Q000276:immunology*; D009469:Neuromuscular Junction / Q000276:immunology; D010396:Penicillamine / Q000009:adverse effects
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D002038:Bungarotoxins; D010396:Penicillamine; D000109:Acetylcholine